Stock listing

Euronext:OSE OSE Immunotherapeutics SA Action

Home listing (Euronext) of OSE Immunotherapeutics SA

Follow OSE Immunotherapeutics SA into a list and get an email when it puts out news.

Share price · EURONEXT:OSE

€2.08 EUR -0.08 (-3.7%)

Close on Oct 19, 2026

Past 3 months -41.9% · daily closes, Jul 6, 2026 – Oct 19, 2026, adjusted for splits
Day range
€2.05 – €2.24 EUROct 19, 2026
Volume
268,874 sharesOct 19, 2026
Market value
€51.42M EURAt the close on Oct 19, 2026 · price × 24.72M shares outstanding
OSE Immunotherapeutics SA logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Euronext:OSE · Home€2.08 EUR-0.08 (-3.7%)268,874€2.24€2.24€2.052€2.16Close on Oct 19, 2026
LSE:0RAD€2.082 EUR-0.102 (-4.7%)5,947€2.152€2.152€2.074€2.184Close on Oct 19, 2026
Frankfurt:6OP€2.39 EUR+0.19 (+8.6%)—€2.39€2.39€2.39€2.20Close on Oct 19, 2026

Daily closes

Last 3 months, Jul 20, 2026 – Oct 19, 2026 · EURONEXT:OSE · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€2.08-0.08-3.7%€2.24€2.24€2.052268,874
€2.16-0.098-4.3%€2.26€2.26€2.16172,095
€2.258+0.198+9.6%€2.058€2.262€2.04262,197
€2.06+0.016+0.8%€2.052€2.098€2.0179,845
€2.044-0.084-3.9%€2.14€2.148€2.04134,675
€2.128-0.006-0.3%€2.134€2.156€2.09873,935
€2.134+0.022+1.0%€2.12€2.186€2.1264,784
€2.112-0.024-1.1%€2.16€2.19€2.06293,120
€2.136-0.024-1.1%€2.16€2.16€2.10843,606
€2.16+0.072+3.4%€2.108€2.204€2.108176,457
€2.088-0.026-1.2%€2.114€2.212€2.082249,850
€2.114-0.06-2.8%€2.15€2.218€2.09124,706
€2.174-0.066-2.9%€2.23€2.236€2.16271,945
€2.24-0.012-0.5%€2.242€2.27€2.17117,031
€2.252-0.116-4.9%€2.364€2.38€2.25144,968
€2.368+0.126+5.6%€2.22€2.44€2.19413,805
€2.242-0.218-8.9%€2.43€2.45€2.24320,479
€2.46-0.138-5.3%€2.642€2.642€2.456104,668
€2.598+0.016+0.6%€2.728€2.788€2.578360,766
€2.582-0.008-0.3%€2.59€2.604€2.54847,367
€2.59-0.04-1.5%€2.63€2.63€2.53687,018
€2.63-0.016-0.6%€2.66€2.748€2.6194,848
€2.646+0.032+1.2%€2.55€2.65€2.53867,806
€2.614-0.052-2.0%€2.66€2.726€2.536107,462
€2.666-0.048-1.8%€2.686€2.74€2.642120,511
€2.714+0.006+0.2%€2.70€2.722€2.6170,162
€2.708-0.04-1.5%€2.738€2.836€2.702128,208
€2.748-0.138-4.8%€2.886€2.958€2.748159,220
€2.886-0.112-3.7%€3.01€3.01€2.844151,290
€2.998-0.06-2.0%€3.09€3.09€2.92287,060
€3.058+0.072+2.4%€3.038€3.096€2.9794,245
€2.986-0.084-2.7%€3.10€3.10€2.922244,384
€3.07-0.142-4.4%€3.24€3.258€3.062196,258
€3.212+0.016+0.5%€3.198€3.32€3.17117,228
€3.196-0.02-0.6%€3.20€3.242€3.17269,800
€3.216+0.026+0.8%€3.208€3.238€3.1857,350
€3.19-0.034-1.1%€3.23€3.31€3.19107,049
€3.224+0.008+0.2%€3.238€3.248€3.1780,728
€3.216+0.004+0.1%€3.202€3.24€3.18657,101
€3.212+0.024+0.8%€3.21€3.242€3.16272,226
€3.188-0.146-4.4%€3.328€3.346€3.18112,844
€3.334-0.01-0.3%€3.324€3.34€3.27115,625
€3.344-0.03-0.9%€3.38€3.44€3.306127,004
€3.374+0.064+1.9%€3.34€3.484€3.274258,021
€3.31-0.04-1.2%€3.35€3.356€3.2966,482
€3.35+0.032+1.0%€3.344€3.39€3.28135,458
€3.318-0.044-1.3%€3.342€3.412€3.26210,834
€3.362+0.01+0.3%€3.398€3.544€3.322401,374
€3.352+0.048+1.5%€3.27€3.43€3.186195,633
€3.304+0.074+2.3%€3.262€3.34€3.226128,782
€3.23-0.10-3.0%€3.35€3.396€3.23124,255
€3.33+0.114+3.5%€3.226€3.33€3.226165,644
€3.216-0.046-1.4%€3.24€3.332€3.216133,483
€3.262+0.05+1.6%€3.222€3.294€3.202123,876
€3.212+0.052+1.6%€3.20€3.312€3.184127,239
€3.16-0.046-1.4%€3.216€3.282€3.156105,831
€3.206-0.002-0.1%€3.23€3.33€3.172206,993
€3.208-0.01-0.3%€3.21€3.316€3.19132,650
€3.218+0.052+1.6%€3.194€3.24€3.18874,890
€3.166-0.04-1.2%€3.192€3.226€3.162126,051
€3.206+0.046+1.5%€3.20€3.296€3.194102,939
€3.16-0.04-1.3%€3.24€3.24€3.1378,561
€3.20+0.016+0.5%€3.20€3.244€3.15106,858
€3.184-0.04-1.2%€3.194€3.234€3.14886,708
€3.224+0.074+2.3%€3.158€3.236€3.1580,326
€3.15-0.072-2.2%€3.19€3.246€3.1572,172
Ticker
Euronext:OSE
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Euronext
Currency
EUR

What changed lately

Latest news

OSE Immunotherapeutics Reports Positive Topline Results of Combi-TED Phase 2 Randomized Trial with Tedopi® (OSE2101) in metastatic Non-Small Cell Lung Cancer

Oct 19, 2026

Closed €2.08 (-3.7%) on Oct 19, 2026

OSE Immunotherapeutics to Present at Chardan’s 10th Annual Healthcare Conference

Oct 15, 2026

Closed €2.26 (+9.6%) on Oct 15, 2026

Informations relatives au nombre total de droits de vote et d’actions composant le capital

Oct 7, 2026

Closed €2.14 (-1.1%) on Oct 7, 2026

OSE Immunotherapeutics Reports its Cash Position as of June 30, 2026, and Provides Business Update

Sep 28, 2026

Closed €2.37 (+5.6%) on Sep 28, 2026

OSE Immunotherapeutics Announces Presentation of Combi-TED Phase 2 Topline Results of Tedopi® in Non-Small Cell Lung Cancer at the ESMO 2026 Meeting

Sep 23, 2026

Closed €2.60 (+0.6%) on Sep 23, 2026

OSE Immunotherapeutics annonce la présentation des principaux résultats de l'étude de Phase 2 Combi-TED de Tedopi® dans le cancer du poumon non à petites cellules au Congrès 2026 de l’ESMO

Sep 22, 2026

Closed €2.60 (+0.6%) on Sep 23, 2026

OSE Immunotherapeutics Welcomes First Patient Dosed by Veloxis in the Phase 2 RENGEVITY-201 Trial Evaluating Pegrizeprument (VEL-101) for the Prevention of Organ Rejection in Kidney Transplant Recipients

Sep 9, 2026

Closed €2.75 (-4.8%) on Sep 10, 2026

OSE Immunotherapeutics se félicite de l’inclusion du premier patient traité par Veloxis dans l’étude de phase 2 RENGEVITY-201 évaluant le pegrizeprument (VEL-101) dans la prévention du rejet d’organe chez les patients transplantés rénaux

Sep 8, 2026

Closed €2.89 (-3.7%) on Sep 9, 2026

OSE Immunotherapeutics to host a KOL webcast dedicated to lusvertikimab on September 2, 2026

Aug 27, 2026

Closed €3.19 (-1.1%) on Aug 28, 2026

OSE Immunotherapeutics Reports Results of its 2026 Annual General Meeting

Jun 24, 2026

All OSE Immunotherapeutics SA news

Decks

OSE Immunotherapeutics SA on 6ix

Sector
Health care
Industry
Biotechnology
News releases
34 in the last 12 months · 62 in all · newest Oct 19, 2026 · oldest 2025
Decks
6 decks · latest Sep 30, 2026

Where OSE Immunotherapeutics SA is listed

ListingExchangeCountryCurrency
Euronext:OSE · Home listing · This pageEuronextFranceEUR
LSE:0RADLSEUnited KingdomEUR
gettex:6OPgettexGermanyEUR
LS Exchange:A14QXPLS ExchangeGermanyEUR
Lang & Schwarz:A14QXPLang & SchwarzGermanyEUR
Tradegate:6OPTradegateGermanyEUR
Aquis:OSEPAquisUnited KingdomEUR
Munich:6OPMunichGermanyEUR
OTC:ORPOFOTCUnited StatesUSD
Aquis:OSEPAquisUnited KingdomEUR
Dusseldorf:6OPDusseldorfGermanyEUR
Frankfurt:6OPFrankfurtGermanyEUR
Hamburg:6OPHamburgGermanyEUR
Stuttgart:6OPStuttgartGermanyEUR

Log in to ask 6ix AI your own questions about OSE Immunotherapeutics SA.